These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12022252)

  • 41. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
    Ferrari R; Ambrosio G; Chiariello M
    Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
    [No Abstract]   [Full Text] [Related]  

  • 42. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
    Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)].
    Perepech NB
    Kardiologiia; 2004; 44(3):106-10. PubMed ID: 15489840
    [No Abstract]   [Full Text] [Related]  

  • 44. Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
    White HD
    Lancet; 2003 Sep; 362(9386):755-7. PubMed ID: 13678865
    [No Abstract]   [Full Text] [Related]  

  • 45. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
    Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
    Chalmers J; Neal B; MacMahon S;
    J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perindopril monotherapy and PROGRESS in Europe.
    Wennberg R; Zimmermann C
    BMJ; 2005 Jul; 331(7510):235-6. PubMed ID: 16037473
    [No Abstract]   [Full Text] [Related]  

  • 48. The EUROPA trial.
    Stoschitzky K
    Lancet; 2003 Dec; 362(9399):1935-6; author reply 1936-7. PubMed ID: 14667757
    [No Abstract]   [Full Text] [Related]  

  • 49. Specific properties and effect of perindopril in controlling the renin-angiotensin system.
    Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination BP therapy cuts second stroke risk in half.
    Geriatrics; 2001 Aug; 56(8):14, 16. PubMed ID: 11505852
    [No Abstract]   [Full Text] [Related]  

  • 51. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perindopril effective in Africa-American hypertensives.
    Cardiovasc J S Afr; 2002; 13(5):265. PubMed ID: 12557873
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
    Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
    [No Abstract]   [Full Text] [Related]  

  • 54. Blocking the renin-angiotensin-aldosterone system or lowering the blood pressure: does EUROPA help?
    Mackay JA
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):205-6. PubMed ID: 14689366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Remodeling with angiotensin-converting enzyme inhibitors: from GISSI to PREAMI].
    Nicolosi GL
    Ital Heart J; 2005 Nov; 6 Suppl 7():33S-39S. PubMed ID: 16485515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction?
    Fournier A; Godefroy O; Oprisiu R; Slama M; Andrejak M
    Stroke; 2003 Jan; 34(1):8-9; author reply 8-9. PubMed ID: 12511742
    [No Abstract]   [Full Text] [Related]  

  • 57. Blood-pressure lowering for the secondary prevention of stroke.
    Staessen JA; Wang J
    Lancet; 2001 Sep; 358(9287):1026-7. PubMed ID: 11589927
    [No Abstract]   [Full Text] [Related]  

  • 58. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
    Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
    Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].
    Negri AL
    Medicina (B Aires); 2003; 63(4):363. PubMed ID: 14518154
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hypertension in the acute phase and in the secondary prevention of stroke].
    Arquizan C
    Rev Prat; 2004 Mar; 54(6):637-40. PubMed ID: 15222615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.